Stride (LRN) is back in focus after reporting third quarter and nine month 2026 results that showed higher sales, mixed profit trends, and fresh guidance that narrows the company’s full year revenue and operating income ranges.
See our latest analysis for Stride.
The latest earnings and guidance arrived after a strong run in the share price, with a year to date share price return of 44.06% and a 3 year total shareholder return of 126.03%. This contrasts sharply with a 1 year total shareholder return of 41.66%, suggesting shorter term momentum has cooled even as longer term holders remain well ahead.
If this earnings story has you thinking about what else is moving in education and skills, it could be a good time to scan 18 top founder-led companies
With Q3 revenue growth, mixed margins, new guidance and the share price already up 44% year to date, the key question now is whether Stride’s current valuation still leaves room for upside or if the market is already pricing in future growth.
Most Popular Narrative: 82.5% Overvalued
According to the most followed narrative for Stride, the fair value is set at $51 per share compared with the last close at $93.08, creating a sizeable valuation gap that frames the current debate around the stock.
Stride does not trade like a high growth technology stock, nor should it. Its value proposition is steadier and more defensive. Education demand does not disappear in recessions, it shifts. The company’s challenge is execution, maintaining academic standards, regulatory compliance, and student outcomes while scaling efficiently.
The fair value call here rests on how far this business model can stretch. It leans heavily on measured revenue expansion, steady margins, and earnings that compound rather than spike. Curious what kind of long term growth arc and profitability assumptions that takes to justify a much lower fair value than today’s price.
Result: Fair Value of $51 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this narrative could be knocked off course by tighter regulation of virtual schooling or weaker student outcomes that call the current premium into question.
Find out about the key risks to this Stride narrative.
Another View: Earnings Multiple Points Lower
That $51 fair value from the narrative contrasts sharply with how the market is currently pricing Stride on earnings. At a P/E of 12.7x versus 18.2x for peers and 16.5x for the wider US Consumer Services group, the stock trades at a clear discount even before you compare with the 19.1x fair ratio.
If the market eventually leans closer to that fair ratio, or simply closes part of the gap with peers and the industry, the risk reward trade off looks very different to an 82.5% overvalued call. The question is which view you think is more fragile as new information comes through: the narrative DCF style fair value, or the current earnings multiple.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With such different signals on value and sentiment in play, it makes sense to look at the full picture quickly and decide where you stand, especially given the company’s rewards that investors are optimistic about, starting with 4 key rewards.
Ready to find your next idea?
If Stride has sharpened your thinking, do not stop here. Broaden your watchlist with focused stock ideas that match different goals and risk levels.
- Target long term potential by scanning companies that screen as screener containing 25 high quality undiscovered gems before they hit everyone else’s radar.
- Prioritise resilience by reviewing 67 resilient stocks with low risk scores that aim to keep portfolio shocks in check when conditions change.
- Strengthen your core holdings with businesses highlighted in the solid balance sheet and fundamentals stocks screener (44 results) so you are not relying on fragile finances.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com